FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to clinical laboratory diagnostics, and can be used for insulin resistance diagnostics in patients with type 1 diabetes mellitus. Flow cytometry is used to assess the level of intracellular lipids in isolated peripheral blood monocytes treated with lipophilic dye Nile Red. At average fluorescence intensity MFI is more than 110.0×103 units, insulin resistance syndrome is diagnosed.
EFFECT: method enables early diagnosis of insulin resistance syndrome in patients with type 1 diabetes mellitus by assessing the level of intracellular lipids by determining MFI of the lipophilic dye Nile Red in monocytes.
1 cl, 7 dwg, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSING THE CASES OF INSULIN RESISTANCE SYNDROME | 1999 |
|
RU2153170C1 |
| METHOD OF TREATING PATIENTS WITH TYPE 2 DIABETES MELLITUS | 2009 |
|
RU2398572C1 |
| METHOD OF EARLY GENETIC DIAGNOSTICS OF RISK FOR DEVELOPING TYPE 2 DIABETES MELLITUS | 2017 |
|
RU2655635C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF DIABETES MELLITUS TYPE | 2021 |
|
RU2788106C1 |
| SOLID DOSAGE FORM OF ANTIDIABETIC DRUG BASED ON N-SUBSTITUTED DERIVATIVE AMRINONE - KINASE INHIBITOR OF GLUCOGEN SYNTHASE | 2016 |
|
RU2663913C1 |
| METHOD FOR SCREENING DIAGNOSIS OF INSULIN RESISTANCE | 2012 |
|
RU2493566C1 |
| METHOD FOR DETERMINATION TYPE 1 DIABETES COMPENSATION FOR ADOLESCENTS | 2015 |
|
RU2613272C1 |
| METHOD OF DIAGNOSING EARLY NEUROLOGICAL DISORDERS IN PATIENTS WITH TYPE 1 DIABETES MELLITUS | 2021 |
|
RU2808480C2 |
| METHOD FOR EARLY NON-INVASIVE DIAGNOSIS OF METABOLIC DISORDERS IN CHILDREN AND ADOLESCENTS | 2020 |
|
RU2734336C1 |
| METHOD FOR EARLY DIAGNOSIS OF INSULIN RESISTANCE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2019 |
|
RU2740587C1 |
